Closed Loop Medicine is a global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimize dosing on an individual level with linked behavior therapy to improve patient outcomes.

Closed Loop Medicine is a TechBio company developing prescription combination drug + software products, to bring forward the promise of precision medicine. 

The Company’s proprietary platform facilitates personalised drug dose optimisation, through integration of drugs and devices with patient-led digital experiences and closed loop models of care.

Innovate UK

IQ Capital

Longwall Venture Partners

Cambridge Angels group

Martlet Capital

Ananda Impact Ventures

Business Growth Fund

Downing Ventures

LifeArc

Meltwind Advisory

Closed Loop Medicine

We are delighted to welcome Kostas Vlassis to Closed Loop Medicine as Chief Technology Officer.
 
Bringing extensive expertise in designing and implementing technology strategies to support product delivery, Konstantinos will oversee design and implementation of technology strategy, engineering resources and infrastructure to support development of our ground-breaking technology platforms. 
 
Great to have you in the team Kostas!
 
Learn more by visiting the link posted in the comments below.
 
#PressRelease #TechBio #NewHire #CFO

Dosis sola facit venenum ‘only the dose makes the poison’ 
 
Don't miss our CEO’s, Hakim Yadi Ph.D. OBE, keynote presentation at Frontiers Health 2023 taking place tomorrow, November 8th in Rome & online. 
 
⌚10:20 AM GMT +1 
 
Learn more here: https://bit.ly/3QD8w8y 
 
#FH23 #DTx #DigitalHealth #Healthcare #TechBio

Our COO, Kate Woolland, will be speaking at the Westminster Health Forum Policy Conference taking place online on November 8th.
 
This event will discuss priorities for improving the prevention, detection and treatment of cardiovascular disease (CVD) in England. It provides an opportunity to assess next steps for integrated cardiovascular services as the Government explores innovative approaches to deliver personalized CVD prevention. 
 
See more here: https://rb.gy/vbzwq
 
#CVD #CardiovascularDisease #England #Healthcare #TechBio #DigitalHealth

Save the date! 
 
Our CEO, Hakim Yadi Ph.D. OBE, has been invited to give a Keynote presentation at the upcoming Frontiers Health Global Conference on November 8th in Rome. 
 
Frontiers Health is a premier global digital health innovation event, focusing on digital therapeutics, healthcare transformation, investments, and more. This year, the conference revolves around compelling themes shaping the future of healthcare, including realizing the potential of digital therapeutics, AI, health equity and more. 
 
Dosis sola facit venenum ‘only the dose makes the poison’ - don't miss Hakim’s insights on the impact of unoptimized dosage on healthcare and the promise of integrating traditional therapeutics, medical devices, and new technologies to help ensure personalized treatments for patients.
 
⌚10:20 AM GMT +1 
 
Learn more and register here: https://bit.ly/3QD8w8y 
 
#FH23 #DTx #DigitalHealth #Healthcare #TechBio

We are looking forward to attending BIO-Europe taking place in Munich, November 6-8! Join us to request a partnering meeting: https://bit.ly/3Sm2CY8
 
#BIOEurope convenes over 5,500 attendees, representing 60 countries and 2,220+ companies, making the event the industry's largest gathering of biopharma professionals in Europe.
 
#TechBio #BioPharma #Munich

Happy Friday! ☀ This week we are delighted to share our interview Q&A with our chair Hakim Yadi Ph.D. OBE, CEO of Closed Loop Medicine. 

In this interview Hakim spoke on how best to partner with pharmaceutical companies, of the need for the DTx Industry to focus on refining business models and the importance of industry collaboration to drive the DTx industry forward. 

Read the full interview below 👇 

_____________________________________

DTx Europe: Berlin will be taking place from December 6th-7th at the Hotel Berlin, Berlin. Register here: https://lnkd.in/eCfEm9jr

In the latest episode of the Women in HealthTech Show, Catherine Davies invited our COO, Kate Woolland, to join and speak more about her professional journey, what led to her joining the digital health ecosystem, and how personalized medicine can transform patient care. 

🩺Talking about the current state of healthcare, Kate explains that historically medications have typically been prescribed based on the average effect that they have on a population, not taking into consideration individual needs and response to treatment. 

💊 This approach leads to many patients being on the wrong dose, not getting optimal outcomes, and experiencing adverse drug reactions. We also know that nearly all women are overmedicated and experience more adverse effects because of the lack of gender diversity in clinical trials. 

In this episode, Kate discusses how our team at Closed Loop Medicine is working to solve these problems. Through optimized drug dosing in combination with digital care, we can support an automated, data driven, personalized therapy for patients, while addressing one of the biggest challenges in modern healthcare – the lack of availability of healthcare professionals. 

Find links to the podcast and more details about the episode in the article “A bitter pill to swallow”, in the comments, below. 

#HealthTech #Podcast #TechBio #Healthcare #DigitalHealth #PersonalizedMedicine

We are delighted to announce that Closed Loop Medicine has secured a spot in the IQVIA Global Accelerator Program 2023! 🎉
 
IQVIA’s Accelerator Program will connect early-stage companies with the global IQVIA ecosystem to foster innovation and help expedite bringing new solutions to the market.
 
As part of the accelerator program we will be working with IQVIA and their clients to develop and validate new ways of working and business models at the interface of technology, health and life sciences to drive progress in key areas in advancing patient-centric solutions.

Congratulations to our fellow cohort participants who, like us, are passionate about unlocking innovative healthcare solutions: Medexprim, Climedo, Docunque, Ephion Health, Intelliseq, Kiro, Pando, Qualifyze, and Seasalt.ai
 
#IQVIAAccelerator #techbio #digitalhealth #healthcare #IQVIA

The Annual British and Irish Hypertension Society (BIHS) meeting is taking place in Aberdeen this week. 
 
On Wednesday morning, in Session 7A, Dr. David Collier, will be presenting further data from our clinical study, PERSONAL COVID-BP, where he was the Principal Investigator. The trial recently completed with Queen Mary University of London and Barts Health Trust. 
 
The trial evaluated our hypertension product, CLM-HT01, which is a single-label combination product designed to support patients in the management of their blood pressure. The preliminary results, published in the Journal of the American College of Cardiology, are very promising and we are looking forward to seeing the final findings published soon! 👩🔬
 
#Hypertension #BloodPressure #BIHS #Aberdeen #QMUL

📢We are hiring!
 
We are looking for a SaMD Project Manager to plan and lead our innovative product development projects. 
 
If you have 5+ years’ experience as a medical device / healthcare project manager and a thorough understanding of software development methodologies, you could be the person we’re looking for! 
 
This is a great time to join our team – find out more and apply here: bit.ly/3EtHARK
 
#London #Hiring #SoftwareasaMedicalDevice #SaMD #ProjectManager

COM:CLOSEDLOOPMEDICINE

Closed Loop Medicine Ltd

Analysis Not Available